Hypertension and hypertensive heart disease remains to be a global health burden. Both the American College of Cardiology / American Heart Association (ACC/AHA) and European Society of Cardiology / European Society of Hypertension (ESC/ESH) recognizes the need for out-of-office blood pressure monitoring to identify both white coat hypertension and masked hypertension. While there is no hard evidence to show long-term benefit of treatment of white coat hypertension with hypertension-mediated organ damage (HMOD) and masked hypertension due to methodological issues in studies, there is a recognized increased CV risk in both entities that may need to be addressed.
This e-learning summarizes the diagnostic approach to masked and white coat hypertension, and reviews the data behind possible management options for these conditions.
Keywords: Hypertension, hypertensive heart disease, masked hypertension, white coat hypertension